Literature DB >> 26734766

Evaluation of in vitro antiprotozoal activity of Ajuga laxmannii and its secondary metabolites.

Irem Atay1,2, Hasan Kirmizibekmez2, Marcel Kaiser3, Galip Akaydin4, Erdem Yesilada2, Deniz Tasdemir5,6.   

Abstract

Context Some Ajuga L. (Lamiaceae) species are traditionally used for the treatment of malaria, as well as fever, which is a common symptom of many parasitic diseases. Objective In the continuation of our studies on the identification of antiprotozoal secondary metabolites of Turkish Lamiaceae species, we have investigated the aerial parts of Ajuga laxmannii. Materials and methods The aerial parts of A. laxmannii were extracted with MeOH. The H2O subextract was subjected to polyamide, C18-MPLC and SiO2 CCs to yield eight metabolites. The structures of the isolates were elucidated by NMR spectroscopy and MS analyses. The extract, subextracts as well as the isolates were tested for their in vitro antiprotozoal activities against Plasmodium falciparum, Trypanasoma brucei rhodesiense, T. cruzi and Leishmania donovani at concentrations of 90-0.123 μg/mL. Results Two iridoid glycosides harpagide (1) and 8-O-acetylharpagide (2), three o-coumaric acid derivatives cis-melilotoside (3), trans-melilotoside (4) and dihydromelilotoside (5), two phenylethanoid glycosides verbascoside (6) and galactosylmartynoside (7) and a flavone-C-glycoside, isoorientin (8) were isolated. Many compounds showed moderate to good antiparasitic activity, with isoorientin (8) displaying the most significant antimalarial potential (an IC50 value of 9.7 μg/mL). Discussion and conclusion This is the first report on the antiprotozoal evaluation of A. laxmannii extracts and isolates. Furthermore, isoorientin and dihydromelilotoside are being reported for the first time from the genus Ajuga.

Entities:  

Keywords:  Antiprotozoal activity; Isoorientin; Lamiaceae; flavonoid; iridoid glycosides; plasmodium

Mesh:

Substances:

Year:  2016        PMID: 26734766     DOI: 10.3109/13880209.2015.1129542

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  6 in total

1.  Isoindolin-1-ones Fused to Barbiturates: From Design and Molecular Docking to Synthesis and Urease Inhibitory Evaluation.

Authors:  Houman Kazemzadeh; Elham Hamidian; Faezeh Sadat Hosseini; Movahed Abdi; Fatemeh Niasari Naslaji; Meysam Talebi; Mehdi Asadi; Mahmood Biglar; Issa Zarei; Massoud Amanlou
Journal:  ACS Omega       Date:  2022-06-02

2.  Chemical Genomic Profiling Unveils the in Vitro and in Vivo Antiplasmodial Mechanism of Açaí (Euterpe oleracea Mart.) Polyphenols.

Authors:  Letícia T Ferreira; Vinícius P Venancio; Taila Kawano; Lailah C C Abrão; Tatyana A Tavella; Ludimila D Almeida; Gabriel S Pires; Elizabeth Bilsland; Per Sunnerhagen; Luciana Azevedo; Stephen T Talcott; Susanne U Mertens-Talcott; Fabio T M Costa
Journal:  ACS Omega       Date:  2019-09-13

3.  Antiprotozoal Activity of Turkish Origanum onites Essential Oil and Its Components.

Authors:  Deniz Tasdemir; Marcel Kaiser; Betül Demirci; Fatih Demirci; K Hüsnü Can Baser
Journal:  Molecules       Date:  2019-12-03       Impact factor: 4.411

Review 4.  Revisiting nature: a review of iridoids as a potential antileishmanial class.

Authors:  Guilherme Arraché Gonçalves; Vera Lucia Eifler-Lima; Gilsane Lino von Poser
Journal:  Phytochem Rev       Date:  2021-03-16       Impact factor: 7.741

5.  Bifurcatriol, a New Antiprotozoal Acyclic Diterpene from the Brown Alga Bifurcaria bifurcata.

Authors:  Vangelis Smyrniotopoulos; Christian Merten; Marcel Kaiser; Deniz Tasdemir
Journal:  Mar Drugs       Date:  2017-08-02       Impact factor: 5.118

6.  Phytochemical Composition, Antioxidant, Antimicrobial and in Vivo Anti-inflammatory Activity of Traditionally Used Romanian Ajuga laxmannii (Murray) Benth. ("Nobleman's Beard" - Barba Împăratului).

Authors:  Anca Toiu; Andrei Mocan; Laurian Vlase; Alina E Pârvu; Dan C Vodnar; Ana-Maria Gheldiu; Cadmiel Moldovan; Ilioara Oniga
Journal:  Front Pharmacol       Date:  2018-03-02       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.